Balyasny Asset Management’s HCA Healthcare HCA Stock Holding History

Balyasny Asset Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-320,000	Closed	-$96M	–	2989
2024 Q4	$96M	Buy	320,000 +317,600	+13,233%	+$111M	0.14%	162
2024 Q3	$975K	Buy	+2,400	New	+$879K	﹤0.01%	1977
2020 Q4	–	Sell	-60,000	Closed	-$7.48M	–	1485
2020 Q3	$7.48M	Buy	+60,000	New	+$7.43M	0.05%	476
2016 Q2	–	Sell	-250,000	Closed	-$19.5M	–	1277
2016 Q1	$19.5M	Buy	+250,000	New	+$17.5M	0.12%	257
2013 Q3	–	Sell	-643,600	Closed	-$23.2M	–	624
2013 Q2	$23.2M	Buy	+643,600	New	+$24.9M	0.39%	50

Other funds holding HCA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Balyasny Asset Management's HCA Position: Q1 2026 in Review

Balyasny Asset Management reduced its HCA Healthcare (HCA) stake by 48% in Q1 2026, selling an estimated $1.15M and leaving 2,508 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2013.

Balyasny Asset Management first reported a position in HCA in Q2 2013 and has held it in 41 quarters since. The position peaked at $63.9M in Q4 2023. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

Balyasny Asset Management held 2,508 shares of HCA Healthcare worth $1.19M as of Q1 2026.
Balyasny Asset Management sold 2,280 HCA Healthcare shares in Q1 2026, an estimated $1.15M.
HCA Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2013 holding.
Balyasny Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 41 quarters since.
Balyasny Asset Management's HCA Healthcare position peaked at $63.9M in Q4 2023.
1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.